136 related articles for article (PubMed ID: 31554861)
1. A multicentre clinical validation of AminoIndex Cancer Screening (AICS).
Mikami H; Kimura O; Yamamoto H; Kikuchi S; Nakamura Y; Ando T; Yamakado M
Sci Rep; 2019 Sep; 9(1):13831. PubMed ID: 31554861
[TBL] [Abstract][Full Text] [Related]
2. Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancer.
Higashiyama M; Miyazaki R; Yamamoto H; Anayama T; Kikuchi S; Hirohashi K; Okami J; Maniwa T; Kimura T; Orihashi K; Imamura F
BMC Cancer; 2020 Nov; 20(1):1100. PubMed ID: 33183251
[TBL] [Abstract][Full Text] [Related]
3. Post-operative AICS status in completely resected lung cancer patients with pre-operative AICS abnormalities: predictive significance of disease recurrence.
Anayama T; Higashiyama M; Yamamoto H; Kikuchi S; Ikeda A; Okami J; Tokunaga T; Hirohashi K; Miyazaki R; Orihashi K
Sci Rep; 2018 Aug; 8(1):12378. PubMed ID: 30120365
[TBL] [Abstract][Full Text] [Related]
4. Perioperative dynamics and significance of plasma-free amino acid profiles in colorectal cancer.
Katayama K; Higuchi A; Yamamoto H; Ikeda A; Kikuchi S; Shiozawa M
BMC Surg; 2018 Feb; 18(1):11. PubMed ID: 29466971
[TBL] [Abstract][Full Text] [Related]
5. Associations of AminoIndex Cancer Screening (Breast) Grade with Clinical and Laboratory Variables.
Jikuzono T; Ishibashi O; Kure S; Ohmae Y; Ohmae T
J Nippon Med Sch; 2022 Aug; 89(4):377-383. PubMed ID: 35082207
[TBL] [Abstract][Full Text] [Related]
6. [Can Plasma Free Amino Acid Profiling Be Used to Assess Cancer Risk?].
Ando T
Rinsho Byori; 2016 Oct; 64(10):1163-1170. PubMed ID: 30609475
[TBL] [Abstract][Full Text] [Related]
7. Early detection of colon cancer by amino acid profiling using AminoIndex Technology: a case report.
Yatabe J; Yatabe MS; Ishibashi K; Nozawa Y; Sanada H
Diagn Pathol; 2013 Dec; 8():203. PubMed ID: 24325735
[TBL] [Abstract][Full Text] [Related]
8. Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening program.
Hamashima C; Sobue T; Muramatsu Y; Saito H; Moriyama N; Kakizoe T
Jpn J Clin Oncol; 2006 May; 36(5):301-8. PubMed ID: 16735372
[TBL] [Abstract][Full Text] [Related]
9. Estimating age group-dependent sensitivity and mean sojourn time in colorectal cancer screening.
Sung NY; Jun JK; Kim YN; Jung I; Park S; Kim GR; Nam CM
J Med Screen; 2019 Mar; 26(1):19-25. PubMed ID: 30261804
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
11. Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study.
Falanga A; Santoro A; Labianca R; De Braud F; Gasparini G; D'Alessio A; Barni S; Iacoviello L;
Thromb Res; 2016 Apr; 140 Suppl 1():S55-9. PubMed ID: 27067979
[TBL] [Abstract][Full Text] [Related]
12. A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile.
Fukutake N; Ueno M; Hiraoka N; Shimada K; Shiraishi K; Saruki N; Ito T; Yamakado M; Ono N; Imaizumi A; Kikuchi S; Yamamoto H; Katayama K
PLoS One; 2015; 10(7):e0132223. PubMed ID: 26133769
[TBL] [Abstract][Full Text] [Related]
13. The benefits of cancer screening in kidney transplant recipients: a single-center experience.
Kato T; Kakuta Y; Abe T; Yamanaka K; Imamura R; Okumi M; Ichimaru N; Takahara S; Nonomura N
Cancer Med; 2016 Feb; 5(2):153-8. PubMed ID: 26686199
[TBL] [Abstract][Full Text] [Related]
14. A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing.
Jiao B; Gulati R; Katki HA; Castle PE; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):38-44. PubMed ID: 34548329
[TBL] [Abstract][Full Text] [Related]
15. The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications.
Doroudi M; Kramer BS; Pinsky PF
J Med Screen; 2017 Dec; 24(4):220-222. PubMed ID: 27903809
[TBL] [Abstract][Full Text] [Related]
16. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
17. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
Dollinger MM; Behl S; Fleig WE
Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
[TBL] [Abstract][Full Text] [Related]
18. [Screening of colorectal cancer in Kunming urban residents from 2014 to 2017].
Zhou H; Zhang X; Shen ZH; Chen XB; Zhao GQ; Lin YP; Huang YC; Zhang Q; Ma J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1058-1063. PubMed ID: 31770837
[No Abstract] [Full Text] [Related]
19. Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes.
Gao Y; Goldberg JE; Young TK; Babb JS; Moy L; Heller SL
Radiology; 2019 Nov; 293(2):282-291. PubMed ID: 31526252
[TBL] [Abstract][Full Text] [Related]
20. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
